Safety Study of SBRT and Docetaxel for Locally Recurrent or Second Primary Squamous Cell Carcinoma of the Head and Neck
Status:
Terminated
Trial end date:
2017-03-29
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety of a chemotherapy drug called
docetaxel and focused radiation therapy (SBRT) and see what effects (good and bad) it has on
recurrent head and neck cancer that is not surgically removable.